Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of Bendamustine and Rituximab Plus Venetoclax in Untreated Mantle Cell Lymphoma Over 60 Years of Age

NCT03834688 is registered in ClinicalTrials.gov with PrECOG, LLC. as lead sponsor.

NCT NCT03834688
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03834688 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of Bendamustine and Rituximab Plus Venetoclax in Untreated Mantle Cell Lymphoma Over 60 Years of Age
Lead sponsor
PrECOG, LLC.
Phase
Phase 2
Overall status
Completed
Start date
January 13, 2020
Completion date
July 26, 2024
Enrollment
33 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

mantle cell lymphoma